ADMA Biologics, Inc. (ADMA)
NASDAQ: ADMA · Real-Time Price · USD
17.20
+0.44 (2.63%)
Aug 13, 2025, 4:00 PM - Market closed
ADMA Biologics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 208.93 | 197.67 | -28.24 | -65.9 | -71.65 | -75.75 | Upgrade
|
| Depreciation & Amortization | 7.91 | 8.05 | 8.33 | 7.11 | 5.5 | 3.94 | Upgrade
|
| Other Amortization | 0.82 | 0.95 | 2.59 | 2.4 | 1.9 | 1.78 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.08 | 0.11 | 0.18 | 0.43 | 0.22 | 0.08 | Upgrade
|
| Stock-Based Compensation | 18.2 | 13.62 | 6.19 | 5.22 | 3.49 | 2.86 | Upgrade
|
| Other Operating Activities | -76.98 | -83.18 | 29.87 | 9.53 | -0.14 | -1.13 | Upgrade
|
| Change in Accounts Receivable | -79.61 | -22.58 | -11.92 | 13.07 | -15.34 | -9.77 | Upgrade
|
| Change in Inventory | -11.65 | 2.67 | -9.63 | -38.56 | -43.19 | -28.47 | Upgrade
|
| Change in Accounts Payable | 14.97 | 4.15 | 3.84 | 0.8 | 1.36 | 1.9 | Upgrade
|
| Change in Other Net Operating Assets | -5.96 | -2.78 | 7.58 | 6.4 | 5.49 | 2.56 | Upgrade
|
| Operating Cash Flow | 76.71 | 118.67 | 8.8 | -59.51 | -112.37 | -102 | Upgrade
|
| Operating Cash Flow Growth | 5.07% | 1248.55% | - | - | - | - | Upgrade
|
| Capital Expenditures | -10.94 | -8.23 | -4.77 | -13.91 | -13.51 | -12.73 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | - | - | 0 | Upgrade
|
| Sale (Purchase) of Intangibles | -0.16 | -0.35 | -0.21 | - | - | - | Upgrade
|
| Investing Cash Flow | -11.1 | -8.58 | -4.98 | -13.91 | -13.51 | -12.72 | Upgrade
|
| Long-Term Debt Issued | - | - | 135 | 151.75 | - | 27.5 | Upgrade
|
| Long-Term Debt Repaid | - | -60 | -158.6 | -100.04 | -0.03 | -13.98 | Upgrade
|
| Net Debt Issued (Repaid) | -60 | -60 | -23.6 | 51.71 | -0.03 | 13.52 | Upgrade
|
| Issuance of Common Stock | 8.3 | 7.49 | 1.1 | 64.82 | 121.14 | 131.21 | Upgrade
|
| Repurchase of Common Stock | -10.22 | -4.97 | -1.42 | -2.9 | -0.06 | - | Upgrade
|
| Other Financing Activities | -1.65 | -0.83 | -15.08 | -4.78 | - | -0.83 | Upgrade
|
| Financing Cash Flow | -63.57 | -58.3 | -38.99 | 108.85 | 121.05 | 143.9 | Upgrade
|
| Net Cash Flow | 2.04 | 51.8 | -35.17 | 35.43 | -4.83 | 29.17 | Upgrade
|
| Free Cash Flow | 65.77 | 110.45 | 4.03 | -73.42 | -125.88 | -114.73 | Upgrade
|
| Free Cash Flow Growth | -1.31% | 2641.28% | - | - | - | - | Upgrade
|
| Free Cash Flow Margin | 13.87% | 25.90% | 1.56% | -47.65% | -155.52% | -271.74% | Upgrade
|
| Free Cash Flow Per Share | 0.27 | 0.45 | 0.02 | -0.37 | -0.90 | -1.33 | Upgrade
|
| Cash Interest Paid | 11.78 | 10.67 | 18.05 | 13.88 | 11.16 | 10.27 | Upgrade
|
| Cash Income Tax Paid | 14.73 | 9.39 | - | - | - | - | Upgrade
|
| Levered Free Cash Flow | 43.69 | 75.16 | 0.38 | -53.5 | -96.39 | -80.49 | Upgrade
|
| Unlevered Free Cash Flow | 49.24 | 82.91 | 13.43 | -43.85 | -90.13 | -74.78 | Upgrade
|
| Change in Working Capital | -82.26 | -18.54 | -10.12 | -18.29 | -51.68 | -33.78 | Upgrade
|
Updated May 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.